Shibing Yang

1.2k total citations
44 papers, 921 citations indexed

About

Shibing Yang is a scholar working on Rheumatology, Pharmacology and Physiology. According to data from OpenAlex, Shibing Yang has authored 44 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 8 papers in Pharmacology and 8 papers in Physiology. Recurrent topics in Shibing Yang's work include Osteoarthritis Treatment and Mechanisms (8 papers), Asthma and respiratory diseases (7 papers) and Allergic Rhinitis and Sensitization (6 papers). Shibing Yang is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (8 papers), Asthma and respiratory diseases (7 papers) and Allergic Rhinitis and Sensitization (6 papers). Shibing Yang collaborates with scholars based in United States, United Kingdom and Belgium. Shibing Yang's co-authors include Kate L. Lapane, Charles B. Eaton, Timothy E. McAlindon, Jau‐Shyong Hong, Pisin Chen, Ganggang Peng, G. Li, Xin Wu, Belinda Wilson and D M Chuang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and American Journal of Epidemiology.

In The Last Decade

Shibing Yang

38 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shibing Yang United States 15 244 232 156 150 140 44 921
Matthias F. Seidel Germany 13 188 0.8× 136 0.6× 121 0.8× 122 0.8× 223 1.6× 38 715
Sara Kelly United Kingdom 16 434 1.8× 186 0.8× 296 1.9× 389 2.6× 148 1.1× 27 965
Christina A. Christianson United States 10 540 2.2× 141 0.6× 78 0.5× 65 0.4× 75 0.5× 16 1.0k
Astrid Kamilla Stunes Norway 19 269 1.1× 368 1.6× 50 0.3× 67 0.4× 100 0.7× 60 1.4k
Jordan Parker United States 26 689 2.8× 377 1.6× 80 0.5× 62 0.4× 71 0.5× 75 1.8k
Ingegerd Söderström Sweden 18 225 0.9× 201 0.9× 63 0.4× 44 0.3× 242 1.7× 26 1.1k
Masood Khan United Kingdom 20 146 0.6× 228 1.0× 96 0.6× 90 0.6× 57 0.4× 81 1.1k
Michael Bliziotes United States 22 207 0.8× 466 2.0× 193 1.2× 134 0.9× 77 0.6× 36 1.5k
Isabelle Davignon United States 13 245 1.0× 367 1.6× 188 1.2× 241 1.6× 279 2.0× 19 1000

Countries citing papers authored by Shibing Yang

Since Specialization
Citations

This map shows the geographic impact of Shibing Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibing Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibing Yang more than expected).

Fields of papers citing papers by Shibing Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shibing Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibing Yang. The network helps show where Shibing Yang may publish in the future.

Co-authorship network of co-authors of Shibing Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shibing Yang. A scholar is included among the top collaborators of Shibing Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shibing Yang. Shibing Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chihara, Dai, et al.. (2025). Real-world treatment patterns and clinical outcomes in patients with follicular lymphoma: a SEER-Medicare analysis. PubMed. 2(2). 100080–100080. 1 indexed citations
2.
Shieh, Wann‐Yun, Yan‐Ying Ju, Shibing Yang, I‐Chun Chen, & Hsin‐Yi Kathy Cheng. (2025). Evaluating Assistive Technology Outcomes in Boccia Athletes with Disabilities Using AI-Based Kinematic Analysis. Bioengineering. 12(7). 684–684.
3.
Rosenthal, Allison, Javier Muñoz, Tongsheng Wang, et al.. (2023). P1149: COMPARISON OF THE EFFICACY OF EPCORITAMAB VERSUS CHIMERIC ANTIGEN RECEPTOR THERAPIES, POLATUZUMAB-BASED REGIMENS, AND TAFASITAMAB-BASED REGIMENS. HemaSphere. 7(S3). e9299527–e9299527.
4.
Hopkins, C, Valerie Lund, Claus Bachert, et al.. (2023). Evaluating treatment response to mepolizumab in patients with severe CRSwNP. Rhinology Journal. 0(0). 0–0. 14 indexed citations
5.
Borish, Larry, Noah Cohen, Geoffrey Chupp, et al.. (2022). Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps. Annals of Allergy Asthma & Immunology. 129(2). 160–168. 17 indexed citations
6.
Nagase, Hiroyuki, Jun Tamaoki, Takeo Suzuki, et al.. (2022). Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan. Pulmonary Pharmacology & Therapeutics. 75. 102130–102130. 8 indexed citations
7.
Bachert, Claus, Peter W. Hellings, Valerie Lund, et al.. (2022). Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP. Rhinology Journal. 0(0). 0–0. 3 indexed citations
8.
Israel, Elliot, Giorgio Walter Canonica, Guy Brusselle, et al.. (2021). Real-life effectiveness of mepolizumab in severe asthma: a systematic literature review. Journal of Asthma. 59(11). 2201–2217. 24 indexed citations
9.
Harrison, Tim, Giorgio Walter Canonica, Geoffrey Chupp, et al.. (2020). Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis. European Respiratory Journal. 56(4). 2000151–2000151. 91 indexed citations
10.
Eaton, Charles B., Jeffrey B. Driban, Shibing Yang, & Bing Lü. (2014). Dietary fat intake and knee osteoarthritis progression: data from the osteoarthritis initiative. Osteoarthritis and Cartilage. 22. S207–S207. 1 indexed citations
11.
Eaton, Charles B., Kate L. Lapane, Molly E. Waring, et al.. (2013). Metabolic syndrome, advanced glycation end products and knee osteoarthritis progression: a report from OAI. Osteoarthritis and Cartilage. 21. S165–S166. 2 indexed citations
12.
Lapane, Kate L., et al.. (2013). CAM use among overweight and obese persons with radiographic knee osteoarthritis. BMC Complementary and Alternative Medicine. 13(1). 241–241. 8 indexed citations
13.
Yang, Shibing, Catherine Dubé, Charles B. Eaton, Timothy E. McAlindon, & Kate L. Lapane. (2013). Longitudinal Use of Complementary and Alternative Medicine Among Older Adults With Radiographic Knee Osteoarthritis. Clinical Therapeutics. 35(11). 1690–1702. 32 indexed citations
14.
Oh, Unsong, et al.. (2013). A Systematic Review of Pharmacological Pain Management in Multiple Sclerosis. Drugs. 73(15). 1711–1722. 33 indexed citations
15.
Lapane, Kate L., et al.. (2013). Sulfonylureas and Risk of Falls and Fractures: A Systematic Review. Drugs & Aging. 30(7). 527–547. 52 indexed citations
16.
Yang, Shibing, et al.. (2012). Racial differences in symptom management approaches among persons with radiographic knee osteoarthritis. BMC Complementary and Alternative Medicine. 12(1). 86–86. 12 indexed citations
17.
Lapane, Kate L., et al.. (2011). Use of complementary and alternative medicine among patients with radiographic-confirmed knee osteoarthritis. Osteoarthritis and Cartilage. 20(1). 22–28. 65 indexed citations
18.
Zhou, Wenjun, et al.. (2011). Glycogen Synthase Kinase-3β Is a Functional Modulator of Serotonin-1B Receptors. Molecular Pharmacology. 79(6). 974–986. 25 indexed citations
19.
Guo, Xiuhua, Zhijuan Jia, Puhong Zhang, et al.. (2009). Impact of mode of transportation on dyslipidaemia in working people in Beijing. British Journal of Sports Medicine. 43(12). 928–931. 5 indexed citations
20.
Chen, Pisin, Ganggang Peng, G. Li, et al.. (2006). Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Molecular Psychiatry. 11(12). 1116–1125. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthias F. Seidel Breakdown of academic impact, for papers by Sara Kelly Breakdown of academic impact, for papers by Christina A. Christianson Breakdown of academic impact, for papers by Astrid Kamilla Stunes Breakdown of academic impact, for papers by Jordan Parker Breakdown of academic impact, for papers by Ingegerd Söderström Breakdown of academic impact, for papers by Masood Khan Breakdown of academic impact, for papers by Michael Bliziotes Breakdown of academic impact, for papers by Isabelle Davignon
Rankless by CCL
2026